7ZI3
Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0642 inhibitor
Summary for 7ZI3
Entry DOI | 10.2210/pdb7zi3/pdb |
Descriptor | Deoxycytidine kinase, 2-[2-[[2-methyl-5-[4-(4-methylpiperazin-1-yl)sulfonyl-2-(trifluoromethyl)phenyl]phenyl]-propyl-amino]-1,3-thiazol-4-yl]pyrimidine-4,6-diamine, URIDINE-5'-DIPHOSPHATE, ... (5 entities in total) |
Functional Keywords | inhibitor, transferase |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 1 |
Total formula weight | 33775.53 |
Authors | Ben-Yaala, K.,Saez-Ayala, M.,Betzi, S.,Rebuffet, E.,Morelli, X. (deposition date: 2022-04-07, release date: 2023-06-07, Last modification date: 2024-02-07) |
Primary citation | Saez-Ayala, M.,Hoffer, L.,Abel, S.,Ben Yaala, K.,Sicard, B.,Andrieu, G.P.,Latiri, M.,Davison, E.K.,Ciufolini, M.A.,Bremond, P.,Rebuffet, E.,Roche, P.,Derviaux, C.,Voisset, E.,Montersino, C.,Castellano, R.,Collette, Y.,Asnafi, V.,Betzi, S.,Dubreuil, P.,Combes, S.,Morelli, X. From a drug repositioning to a structure-based drug design approach to tackle acute lymphoblastic leukemia. Nat Commun, 14:3079-3079, 2023 Cited by PubMed: 37248212DOI: 10.1038/s41467-023-38668-2 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.9 Å) |
Structure validation
Download full validation report